SeraCare Life Sciences (SRLS)

[mlkrborn]

Seracare Life Sciences shareholders approve acquisition by Linden Capital Partners (SRLS) 4.00 +0.01 : Under the terms of the merger agreement, holders of outstanding shares of common stock of SeraCare will receive $4.00 per share. The transaction is expected to close on Friday, April 20, 2012 after the close of business, subject to the satisfaction of customary closing conditions. In addition, shareholders also voted to approve certain compensation arrangements for SeraCare's named executive officers in connection with the merger.